0
Abstract: Slide Presentations |

TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION PREDICTS MORTALITY IN PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH SCLERODERMA FREE TO VIEW

Stephen C. Mathai, MD*; Paul R. Forfia, MD; Micah R. Fisher, MD; Traci Housten-Harris, RN, MS; Reda E. Girgis, MBBS, FCCP; Paul M. Hassoun, MD
Author and Funding Information

Johns Hopkins University, Baltimore, MD



Chest. 2006;130(4_MeetingAbstracts):120S. doi:10.1378/chest.130.4_MeetingAbstracts.120S-c
Text Size: A A A
Published online

Abstract

PURPOSE: Right ventricular (RV) function, as assessed hemodynamically, has prognostic value in pulmonary arterial hypertension (PAH). Despite similar hemodynamic characteristics, patients with PAH associated with scleroderma (PAH-SSD) have poorer response to therapy and worse prognosis compared to other forms of PAH. Because rapid clinical deterioration is common in PAH-SSD, non-invasive measures of RV function are particularly important. We examined whether the tricuspid annular plane systolic excursion (TAPSE) is a useful measure of RV function with prognostic significance in PAH-SSD.

METHODS: 24 consecutive patients with PAH-SSD underwent right heart catheterization (RHC), trans-thoracic echocardiogram (TTE) and were followed prospectively. Measures of RV function were assessed on TTE, including TAPSE (the total displacement of the tricuspid annulus from end-diastole to end-systole). The ability of TAPSE to detect RV systolic dysfunction was tested using ROC curves comparing TAPSE to RV stroke volume index and cardiac index. Time-to-event analyses were performed to examine the relationship between TTE-derived measures of RV function and survival.

RESULTS: RHC revealed moderate to severe PAH (mean RAP 11±6 mmHg, mean PAP 46±9 mmHg, mean CI 2.2±0.6 L/min/m2, mean PVR 11±5 Wood units). The reproducibility of TAPSE was excellent. 13 of 24 patients died in the follow up period (median 16.7 months, range 1.1-25.9). Median survival was 15.1 months. One-year survival estimates based on TAPSE were 86% (95% CI, 33-98%) for the group with TAPSE > 1.8cm and 47% (95% CI, 23-68%) for the group with TAPSE < 1.8cm (log-rank P=0.02). In univariable Cox proportional hazards analysis, TAPSE <1.8cm conferred a 7.5-fold increased risk of death compared to those with a TAPSE > 1.8cm (95% CI, 1.1-57.7, P = 0.05). When included as a continuous variable, for every decrease in TAPSE of 1mm, the risk of death increased by 15% (HR 1.15, 95% CI, 1.01-1.31, P = 0.04).

CONCLUSION: In patients with PAH-SSD, TAPSE is a simple and reproducible assessment of RV function with strong prognostic value.

CLINICAL IMPLICATIONS: Future studies of TAPSE in PAH should be conducted to confirm these findings.

DISCLOSURE: Stephen Mathai, None.

Tuesday, October 24, 2006

10:30 AM - 12:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543